MCH ANALYSIS RESEARCHMain site ↗
Ranking

Most Overvalued

General and impersonal investment research. Not personal financial advice. Forecasts, valuations and model outputs are estimates and may be wrong. See Investment Disclaimer.

Screen output — not a recommendation. How each ranking is defined.

Triangulated fair value furthest below price (FV ÷ price − 1). Ratings as of 2026-10-10 (today) for most names; a few held names carry earlier dates.

The forecast record, beside the forecasts. Across 478 scored pre-registered anchors (of 480), the direction implied by our targets has been right 55.2% of the time, above the 50% a coin flip would give, by more than sampling noise at this sample size. Read as probabilities, the targets score worse than a coin flip: a proxy Brier score of 0.253 against 0.25 (lower is better); the probabilities are reconstructed from the price targets, because the engine only began publishing its own on 2026-08-04. Samples are thin and windows short; nothing is settled in either direction. Full accuracy record →

Ranking 830 of 881 covered names with fv vs price data; top 25 shown.

#CompanyIndustryRatingFV vs priceUpdated
1EverpurePTechnology Hardware, Storage & PeripheralsSELL-60.5%10 October 2026
2Marathon PetroleumMPCOil & Gas Refining & MarketingSELL-57.3%10 October 2026
3Louisiana-PacificLPXBuilding ProductsSELL-54.1%10 October 2026
4Hewlett Packard EnterpriseHPETechnology Hardware, Storage & PeripheralsSELL-52.6%10 October 2026
5ValarisVALOil & Gas DrillingSELL-52.1%10 October 2026
6Phillips 66PSXOil & Gas Refining & MarketingSELL-52.1%10 October 2026
7Palo Alto NetworksPANWSystems SoftwareSELL-51.1%10 October 2026
8CrowdStrikeCRWDSystems SoftwareSELL-50.1%10 October 2026
9CoinbaseCOINFinancial Exchanges & DataSELL-48.6%10 October 2026
10Advanced Micro DevicesAMDSemiconductorsSELL-48.0%10 October 2026
11Space Exploration Technologies Corp. Class A Common Stock (SPCX)SPCXAlternative CarriersSELL-47.9%10 October 2026
12Flagstar BankFLGRegional BanksSELL-47.9%10 October 2026
13AvantorAVTRLife Sciences Tools & ServicesSELL-47.4%10 October 2026
14HumanaHUMManaged Health CareSELL-45.5%10 October 2026
15Valero EnergyVLOOil & Gas Refining & MarketingSELL-45.1%10 October 2026
16Tenet HealthTHCHealth Care FacilitiesSELL-43.7%10 October 2026
17Vicor CorporationVICRElectrical Components & EquipmentSELL-42.3%10 October 2026
18Illumina, Inc.ILMNLife Sciences Tools & ServicesSELL-41.7%10 October 2026
19Veeva SystemsVEEVHealth Care TechnologySELL-41.2%10 October 2026
20Okta, Inc.OKTAApplication SoftwareSELL-41.1%10 October 2026
21IQVIAIQVLife Sciences Tools & ServicesSELL-40.9%10 October 2026
22Zebra TechnologiesZBRAElectronic Equipment & InstrumentsSELL-40.6%10 October 2026
23Ensign GroupENSGHealth Care FacilitiesSELL-40.6%10 October 2026
24IntelINTCSemiconductorsSELL-40.0%10 October 2026
25Robinhood MarketsHOODInvestment Banking & BrokerageSELL-40.0%10 October 2026

Change tracking is unavailable for this metric — its source feed keeps no history. The four ROS-native rankings (fair value vs price, expected return, quality, moat) carry day-over-day motion.

Other rankings: Top Fair-Value Upside · Largest Probability-Weighted Target Upside · Biggest Drawdown · Closest to 52-Week Low · Closest to 52-Week High · Lowest Forward P/E · Highest Forward P/E · Largest by Market Cap · Best Bull / Bear Scenario Ratio · Largest Fair Value vs Price (Engine Field) · Highest MCH Estimated 12-Month Return · Lowest Downside Probability · Highest Quality · Widest Moat · Biggest House-vs-Consensus

MCH ANALYSIS · All research · Research, not personal financial advicemchadvisoryservices.com ↗ · Research Standard v4 (decision-level) · Research OS ros-1.20.0 · US-listed

MCH Analysis is a general investment-research publication of MCH Advisory (Pty) Ltd. It is not personal financial advice and does not take your circumstances into account. MCH is not a licensed financial services provider or a registered investment adviser. Past performance, whether actual or simulated, does not predict future results. Subscriber Agreement | Privacy and Cookie Notice | Research Governance Policies